Encompass Health (EHC) Rides on Solid Revenues, Expansion Plans
Encompass Health (EHC) continues to gain, courtesy of sustained growth in revenues, sound expansion endeavors across the United States and a robust 2021 business outlook.
Encompass Health Corporation EHC remains well-poised for growth on the back of solid top-line growth, continuous addition of facilities to its existing network and robust liquidity position. A strong 2021 outlook reinforces growth prospects of the stock.
Let’s delve deeper and analyze the factors aiding Encompass Health.
Impressive Earnings Surprise History
Encompass Health boasts of a robust earnings surprise record. It has outpaced estimates in each of the trailing four quarters, the average surprise being 14.81%.
Solid 2021 Outlook
The healthcare provider exhibits a robust business outlook for this year. Revenues are anticipated to be $5.10-$5.25 billion, which is higher from the previous guidance of $5.06-$5.23 billion. The mid-point of the newly-provided forecast indicates an improvement of 11.4% from the reported figure at 2020-end.
Adjusted earnings per share from continuing operations is estimated to be $4.32-$4.47 band, up from the prior guidance of $3.94-$4.16. The mid-point of the revised guidance suggests a surge of 52.1% from the 2020-end reported figure.
Continued Top-Line Growth
Revenues of Encompass Health have been on the rise since 2010. The first half of 2021 was no exception to the trend and benefited on the back of higher volumes and favorable pricing across its Inpatient Rehabilitation, and Home Health and Hospice segments.
Continued demand for enhanced rehabilitation care, as patients not only require proper treatment and medication for recovery but also need comprehensive rehabilitation services to return to normal daily activities, is likely to continue driving revenues in the days ahead. Over the 2020-2025 period, the company’s revenue growth is anticipated in the range of 8% to 10%.
Notable Expansion Endeavors
The healthcare provider continues to pursue growth initiatives by either inaugurating hospitals or adding beds to its existing facilities, which should contribute to the revenue growth in the long term. The year 2021 so far has been no exception to the abovementioned trend, and announcements of more growth-related endeavors are expected through the remainder of the year.
There are several growth-related initiatives lined up in its pipeline, which the company plans to pursue over the next few years. In 2022, the company is expected to open 12 hospitals. Besides, it has already unveiled plans to open nine hospitals and one hospital in 2023 and 2024, respectively.
Encompass Health boasts a robust financial position. It possesses sufficient cash reserves and has nearly $917 million available under its $1 billion revolving credit facility at June-end.
The company has been generating solid cash flows from operations, which enables it to pursue growth-related efforts and tactical deployment of capital. In the first half of 2021, net cash provided by operating activities surged 64.7% from the prior-year comparable period. Over the 2020-2025 period, the company anticipates seeing a CAGR of 5-7% for adjusted free cash flow. The improving trend in leverage ratio since 2020 till the second quarter of 2021 looks good.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Humana Inc. (HUM): Free Stock Analysis Report
Molina Healthcare, Inc (MOH): Free Stock Analysis Report
Select Medical Holdings Corporation (SEM): Free Stock Analysis Report
Encompass Health Corporation (EHC): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research